Period:
Draw Mode:
| Volume | 367,304 |
|
|||||
| News | - | ||||||
| Day High | 0.1347 | Low High |
|||||
| Day Low | 0.1263 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alaunos Therapeutics Inc | TCRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0044 | -3.34% | 0.1274 | 14:14:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1294 | 0.1263 | 0.1347 | 0.1318 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 769 | 367,304 | $ 0.129471 | $ 47,555 | - | 0.1111 - 1.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:16:31 | 100 | $ 0.1274 | USD |
Alaunos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 30.87M | 240.63M | - | 2.92M | -37.73M | -0.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alaunos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TCRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1263 | 0.15 | 0.1263 | 0.1348501 | 986,038 | 0.0011 | 0.87% |
| 1 Month | 0.1425 | 0.155 | 0.1111 | 0.1343137 | 1,410,842 | -0.0151 | -10.6% |
| 3 Months | 0.4762 | 0.5099 | 0.1111 | 0.1743248 | 2,204,332 | -0.3488 | -73.25% |
| 6 Months | 0.62 | 0.698 | 0.1111 | 0.2515968 | 1,333,478 | -0.4926 | -79.45% |
| 1 Year | 1.75 | 1.85 | 0.1111 | 0.5572427 | 1,323,076 | -1.62 | -92.72% |
| 3 Years | 0.866 | 4.01 | 0.1111 | 1.08 | 2,111,573 | -0.7386 | -85.29% |
| 5 Years | 0.866 | 4.01 | 0.1111 | 1.08 | 2,111,573 | -0.7386 | -85.29% |
Alaunos Therapeutics Description
| Ziopharm Oncology Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Ziopharm Oncology Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Ziopharm Oncology Inc. ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad. |